Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

N/ACompletedNCT00559689

Hamamatsu University24 enrolled

Overview

Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Asthma

Interventions

Budesonide,hydrofluoroalkane-beclomethasone dipropionateDRUG

receive twice-daily administration

Budesonide,hydrofluoroalkane-beclomethasoneDRUG

once-daily administration at bedtime

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Receive ICS for one year or more, with no change in dose within the previous 8 weeks Exclusion Criteria: * Two or more courses of oral corticosteroid in the previous 12 months * Admission to hospital due to asthma in the previous 6 months * Admission to the intensive care unit due to asthma at any time in the past * Current cigarette smoker.

Locations (1)

Hamamatsu University School of Medicine

Hamamatsu, Japan

Outcomes

Primary Outcomes

once-daily administration of inhaled glucocorticosteroids can control airway inflammation

Time frame: two-year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.